World Trade Center Health Program Scientific/Technical Advisory Committee (WTCHP STAC or Advisory Committee), National Institute for Occupational Safety and Health (NIOSH), 14017 [2012-5624]

Agencies

• Centers for Disease Control and Prevention
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 77, Number 46 (Thursday, March 8, 2012)]
[Notices]
[Page 14017]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-5624]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


World Trade Center Health Program Scientific/Technical Advisory 
Committee (WTCHP STAC or Advisory Committee), National Institute for 
Occupational Safety and Health (NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
committee:

    Time and Date: 1 p.m.-5 p.m., March 28, 2012.
    Place: This meeting is available via telephone and Web 
Conference. Audio will be available by telephone and visuals will be 
available by Web Conference. The USA toll-free, dial-in number is 1-
800-593-0693. To be connected to the meeting, you will need to 
provide the following participant code to the operator: 4447238. To 
obtain further instructions on how to access the meeting online 
through Web Conference, see the instructions at the Committee's Web 
site: https://www.cdc.gov/NIOSH/topics/wtc/stac/meetings/.
    Public Comment Times and Date: 1:10 p.m.-1:55 p.m., March 28, 
2012.
    Please note that the public comment period ends at the time 
indicated above or following the last call for comments, whichever 
is earlier. Members of the public who want to comment must sign up 
by providing their name by mail, facsimile, email, or telephone, as 
given below. Each commenter will be provided up to five minutes for 
comment. A limited number of time slots are available and will be 
assigned on a first come-first served basis. Written comments will 
also be accepted from those unable to attend the public session.
    Status: Open to the public, limited only by the number of 
telephone lines. The conference line will accommodate up to 300 
callers; therefore it is suggested that those interested in calling 
in to listen to the committee meeting share a line when possible.
    Background: The Advisory Committee was established by Public Law 
111-347 (The James Zadroga 9/11 Health and Compensation Act of 2010, 
Title XXXIII of the Public Health Service Act), enacted on January 
2, 2011 and codified at 42 U.S.C. 300mm-300mm-61.
    Purpose: The purpose of the Advisory Committee is to review 
scientific and medical evidence and to make recommendations to the 
World Trade Center (WTC) Program Administrator regarding additional 
WTC Health Program eligibility criteria and potential additions to 
the list of covered WTC-related health conditions. Title XXXIII of 
the Public Health Service Act established within the Department of 
Health and Human Services (HHS), the World Trade Center (WTC) Health 
Program, to be administered by the WTC Program Administrator. The 
WTC Health Program provides: (1) Medical monitoring and treatment 
benefits to eligible emergency responders and recovery and cleanup 
workers (including those who are Federal employees) who responded to 
the September 11, 2001, terrorist attacks, and (2) initial health 
evaluation, monitoring, and treatment benefits to residents and 
other building occupants and area workers in New York City, who were 
directly impacted and adversely affected by such attacks 
(``survivors''). Certain specific activities of the WTC Program 
Administrator are reserved to the Secretary, HHS, to delegate at her 
discretion; other WTC Program Administrator duties not explicitly 
reserved to the Secretary, HHS, are assigned to the Director, NIOSH. 
The administration of the Advisory Committee established under 
Section 300mm-1(a) is left to the Director of NIOSH in his role as 
WTC Program Administrator. CDC and NIOSH provide funding, staffing, 
and administrative support services for the Advisory Committee. The 
charter was issued on May 12, 2011, and will expire on May 12, 2013.
    Matters To Be Discussed: The agenda for the Advisory Committee 
meeting includes the petition to add cancer, or types of cancer, to 
the list of covered WTC-related health conditions. The agenda is 
subject to change as priorities dictate. In the event an individual 
cannot attend, written comments may be submitted. The comments 
should be limited to two pages and submitted to the contact person 
below by March 23, 2012. Efforts will be made to provide the two-
page written comments received by the deadline below to the 
committee members before the meeting. Comments in excess of two 
pages will be made publicly available at the NIOSH docket (https://www.cdc.gov/niosh/docket/archive/docket248.html).
    Public Comment Sign-up and Submissions to the Docket: To sign up 
to provide public comments or to submit comments to the docket, send 
information to the NIOSH Docket Office by one of the following 
means:
    Mail: NIOSH Docket Office, Robert A. Taft Laboratories, MS-C-34, 
4676 Columbia Parkway, Cincinnati, Ohio 45226.
    Facsimile: (513) 533-8285.
    Email: nioshdocket@cdc.gov.
    Telephone: (513) 533-8611.
    Submissions to the docket should reference docket 248.
    Policy on Redaction of Committee Meeting Transcripts (Public 
Comment): Transcripts will be prepared and posted to NIOSH Docket 
248 within 60 days after the meeting. If a person making a comment 
gives his or her name, no attempt will be made to redact that name. 
NIOSH will take reasonable steps to ensure that individuals making 
public comments are aware of the fact that their comments (including 
their name, if provided) will appear in a transcript of the meeting 
posted on a public Web site. Such reasonable steps include a 
statement read at the start of the meeting stating that transcripts 
will be posted and names of speakers will not be redacted. If 
individuals in making a statement reveal personal information (e.g., 
medical information) about themselves, that information will not 
usually be redacted. The CDC Freedom of Information Act coordinator 
will, however, review such revelations in accordance with the 
Freedom of Information Act and if deemed appropriate, will redact 
such information. Disclosures of information concerning third party 
medical information will be redacted.
    Contact Person for More Information: Paul J. Middendorf, Ph.D., 
Designated Federal Officer, NIOSH, CDC, 4676 Columbia Parkway Mail 
Stop R-45, Cincinnati, Ohio 45226, telephone 1 (888) 982-4748; 
email: wtc-stac@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: March 21, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2012-5624 Filed 3-7-12; 8:45 am]
BILLING CODE 4163-18-P